Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Cryptocurrencies Turn Higher as Equities Change Course -- Market Talk

Cryptocurrencies Turn Higher as Equities Change Course -- Market Talk

Dow JonesDow Jones2026/10/19 15:19

1119 ET - Major cryptocurrencies are mostly higher, reversing from losses seen last week. The S&P 500 is up 0.8%, in turn giving cryptocurrencies support to rebound from its recent weakness. "Renewed buying has helped stabilize market sentiment, but the foundations of the recovery remain fragile as interest rate pressures persist and investment flows have yet to improve meaningfully," says Linh Tran of XS.com in a note. Lacking spot buying weighs on the crypto complex, but data from Coinglass shows that volumes being traded are significantly higher in the past 24 hours - with bitcoin volume at $53.9 billion, up 57% in the past 24 hours. Bitcoin rises 1.6% to $82,186, ethereum up 2.4% to $2,405, and XRP up 3.2% to $1.30. ([email protected])

(END) Dow Jones Newswires

October 19, 2026 11:19 ET (15:19 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12